Literature DB >> 18523505

Ketamine treatment for intractable pain in a patient with severe refractory complex regional pain syndrome: a case report.

Peyman Shirani1, Alicia R Salamone, Paul E Schulz, Everton A Edmondson.   

Abstract

In this case report, we describe the effect of ketamine infusion in a case of severe refractory complex regional pain syndrome I (CRPS I). The patient was initially diagnosed with CRPS I in her right upper extremity. Over the next 6 years, CRPS was consecutively diagnosed in her thoracic region, left upper extremity, and both lower extremities. The severity of her pain, combined with the extensive areas afflicted by CRPS, caused traumatic emotional problems for this patient. Conventional treatments, including anticonvulsants, bisphosphonates, oral steroids and opioids, topical creams, dorsal column spinal cord stimulation, spinal morphine infusion, sympathetic ganglion block, and sympathectomy, failed to provide long-term relief from pain. An N-methyl-d-aspartate (NMDA) antagonist inhibitor, ketamine, was recently suggested to be effective at resolving intractable pain. The patient was then given several infusions of intravenous ketamine. After the third infusion, the edema, discoloration, and temperature of the affected areas normalized. The patient became completely pain-free. At one-year of follow-up, the patient reported that she has not experienced any pain since the last ketamine infusion. Treatment with intravenous ketamine appeared to be effective in completely resolving intractable pain caused by severe refractory CRPS I. Future research on this treatment is needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523505

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  5 in total

Review 1.  Efficacy and safety of ketamine in patients with complex regional pain syndrome: a systematic review.

Authors:  Pari Azari; David R Lindsay; Dean Briones; Collin Clarke; Thomas Buchheit; Srinivas Pyati
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

Review 2.  Novel Approaches for Treating Pain in Children.

Authors:  William Splinter
Journal:  Curr Oncol Rep       Date:  2019-02-04       Impact factor: 5.075

3.  Efficacy of stellate ganglion block with an adjuvant ketamine for peripheral vascular disease of the upper limbs.

Authors:  Kalpana R Kulkarni; Anita I Kadam; Ismile J Namazi
Journal:  Indian J Anaesth       Date:  2010-11

4.  Preventive Treatment with Ketamine Attenuates the Ischaemia-Reperfusion Response in a Chronic Postischaemia Pain Model.

Authors:  Suryamin Liman; Chi Wai Cheung; Kar Lok Wong; Wai Tai; Qiu Qiu; Kwok Fu Ng; Siu Wai Choi; Michael Irwin
Journal:  Oxid Med Cell Longev       Date:  2015-06-16       Impact factor: 6.543

5.  Ketamine as an adjuvant in sympathetic blocks for management of central sensitization following peripheral nerve injury.

Authors:  Rani A Sunder; Gokul Toshniwal; G P Dureja
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2008-10-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.